In the BioHarmony Drug Report Database
Strattera (atomoxetine) is a small molecule pharmaceutical. Atomoxetine was first approved as Strattera on 2002-11-26. It is used to treat attention deficit disorder with hyperactivity in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter. In addition, it is known to target sodium-dependent dopamine transporter and sodium-dependent serotonin transporter.
Image (chem structure or protein)